Melanoma treatment varies depending on the cancer’s stage.
The main treatment option for melanoma is surgery. Doctors can use other approaches to kill remaining cancer cells after surgery or to treat people for whom surgery isn’t an option.
In this article, we’ll go over several treatment options used for melanoma skin cancer. If you have questions about your specific melanoma treatment plan, talk to your oncologist (cancer specialist). They can also help you manage any treatment side effects you may experience.
Most people with melanoma will have surgery at some point in their treatment journey. For those with early-stage (stages 1 and 2) melanoma, surgery can usually cure their cancer. The type of surgery your oncologist chooses depends on how large the tumor is and where it’s located.
Melanoma is diagnosed with a biopsy — a procedure that removes a tissue sample to look at under a microscope. Surgeons take some of the tumor during a biopsy, but more surgery is likely needed to completely remove it.
Wide excision surgery removes the tumor along with tissue from a margin or area surrounding the tumor. This procedure helps make sure no melanoma cells are left behind.
Mohs surgery — or Mohs micrographic surgery — is a procedure sometimes used to treat melanoma in areas where a wide excision would be difficult. It involves removing thin layers of skin and examining them with a microscope until only cancer-free tissues remain. Some studies show it may be useful for treating early-stage melanoma, but not all doctors agree on its use.
Melanoma can also spread into nearby lymph nodes. These tiny organs filter out infections and cancer cells. Oncologists may biopsy or remove lymph nodes as needed to treat melanoma. This helps stop melanoma from spreading to other places in the body.
Immunotherapy uses lab-made protein drugs to activate the body’s immune system against cancer. The U.S. Food and Drug Administration (FDA) has approved several immunotherapy drugs for treating melanoma.
Immunotherapy may be used to treat stages 2, 3, and 4 melanoma. Oncologists can give immunotherapy on its own or as a treatment after surgery, known as adjuvant therapy. The goal of adjuvant therapy is to kill any cancer cells left behind after surgery. It helps reduce the chances of melanoma returning.
Some people have melanomas that make specialized proteins that help them hide from the immune system. These proteins work as an “off switch,” turning off immune cells known as T cells.
If the T cells are switched off, they’re unable to identify cancer cells to eliminate them from the body. As a result, the melanoma tumors can keep growing and spreading.
Doctors and researchers have developed medication known as immune checkpoint inhibitors (ICIs). They work by blocking the “off switch” proteins, allowing T cells to attack and destroy melanoma cells.
There are several FDA-approved ICIs for advanced melanoma, including:
Oncolytic virus therapy is another type of immunotherapy that may be used for melanoma. An oncolytic virus is a lab-engineered virus that specifically attacks and kills cancer cells. It’s important to note that the virus won’t attack your body’s healthy cells.
In 2015, the FDA approved talimogene laherparepvec (T-VEC, sold as Imlygic) for treating advanced melanoma. Specifically, it’s used to treat melanoma that can’t be fully removed with surgery.
T-VEC is injected directly into melanoma tumors found on the skin, underneath the skin, or within lymph nodes. The virus enters the melanoma cells and begins replicating (making more copies of itself). Eventually, the melanoma cells burst open and die, and the tumor shrinks.
More recently, in 2026, the FDA approved vusolimogene oderparepvec-wtpg (Tudriqev). Vusolimogene oderparepvec-wtpg is another oncolytic viral therapy indicated to treat melanoma that can’t be removed by surgery.
To be eligible for vusolimogene oderparepvec-wtpg, your melanoma must have progressed despite treatment with a drug that blocks a protein known as PD-1. Vusolimogene oderparepvec-wtpg is used in combination with nivolumab.
Scientists are always finding new ways to treat diseases. In 2022, the FDA approved tebentafusp-tebn (Kimmtrak). Specifically, tebentafusp-tebn is used to treat uveal melanoma (affecting the eyes) that can’t be treated with surgery or has spread to other parts of the body.
Tebentafusp-tebn is an engineered protein with two parts, known as a bispecific T-cell engager. One part attaches to melanoma cells, and the other attaches to T cells. This connection helps the immune system attack and destroy melanoma tumors.
You’ll need to have testing first to make sure the tebentafusp treatment will work for you.
Interleukins (ILs) are inflammatory proteins normally made by your immune system. An IL-2 called aldesleukin (Proleukin) is an immunotherapy that can help activate the immune system to fight stage 4 melanoma, also known as metastatic melanoma.
Studies show that IL-2 may not be the most effective treatment for some people. With more immunotherapy options available, it’s not widely used anymore.
Tumor-infiltrating lymphocytes (TILs) are another newer type of immunotherapy. Lifileucel (Amtagvi) was approved in 2024 as the first TIL therapy to treat cancer. Specifically, lifileucel is used to treat advanced melanoma that has become worse after a person has tried other immunotherapies or targeted therapies.
With TIL therapy, T cells (a type of immune cell that can attack and kill cancer) are first collected from your tumor. They’re then shipped to a lab, where they are reproduced in large numbers and combined with a drug that encourages them to attack your tumor cells more aggressively. Finally, lifileucel is infused back into your body to begin attacking melanoma cells.
Before receiving lifileucel, you must undergo some chemotherapy to reduce the number of other immune cells.
Targeted therapies work by “targeting” or blocking abnormal proteins made by melanoma cells. According to the American Cancer Society, around 50 percent of melanomas have mutations or changes in the BRAF gene.
BRAF proteins work together with MEK proteins to send growth signals in cells. By blocking these proteins in melanoma cells, targeted therapies help shrink tumors.
The FDA has approved several targeted therapies for melanoma. These medications are used to treat melanoma that has spread or can’t be removed with surgery. BRAF inhibitors for melanoma include:
Examples of MEK inhibitors include:
Studies show that BRAF and MEK inhibitors work best when they’re used together in specific combinations. For example, dabrafenib and trametinib can be used as an adjuvant treatment for people with stage 3 melanoma. This helps prevent the cancer from returning.
Targeted therapies can also be combined with immunotherapy. A combination of atezolizumab, cobimetinib, and vemurafenib can be used to treat melanoma with BRAF V600 mutations.
Chemotherapy and radiation therapy are a major part of most cancer treatment plans. However, they’re not often used to treat melanoma.
Chemotherapy uses toxic chemicals that kill rapidly dividing cells. It may be used to treat metastatic melanoma after trying other treatment options.
Chemotherapy can help shrink tumors in some people, but it may not work for everyone. In mid-2023, the FDA approved the Hepzato Kit, which delivers the chemotherapy drug melphalan directly to the liver. This is a treatment option for people with uveal melanoma that’s spread to the liver.
Radiation therapy uses concentrated beams of radiation to damage melanoma cells. It may be used:
Clinical trials are vital to developing new treatments for melanoma. Participating in cancer research may also give you access to new types of treatments. If you’re interested in learning more about what’s involved in joining a study focused on the treatment of melanoma, talk to your oncologist.
Your oncologist may also recommend lifestyle changes to improve your overall health and lower the risk of your melanoma returning.
Be sure to wear sunscreen and protective clothing to shield yourself from the sun. You should also regularly check your skin for any new signs of melanoma. Your doctor may also encourage you to eat a healthy diet and quit smoking (if you do smoke).
Get updates directly to your inbox.
What is the treatment for stage 0 and 1
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
T
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.